Cost-effectiveness analyses, which are often conducted to evaluate new medicines, use a standardized framework to inform health care decision makers. However, a one-size-fits-all approach to ...

Survival extrapolation plays a pivotal role in cost-effectiveness analysis by extending observed clinical trial data to estimate long-term patient outcomes. Given that the follow‐up periods of trials ...

This commentary argues that practitioners of cost-effectiveness analyses should incorporate dynamic drug pricing into formal cost-effectiveness analyses (CEAs). For reasons we discuss, doing so will ...

Health economics provides a framework for evaluating the allocation of limited resources in healthcare, ensuring that interventions not only deliver clinical benefit but also represent optimal use of ...